1. Home
  2. IRWD vs GDO Comparison

IRWD vs GDO Comparison

Compare IRWD & GDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRWD
  • GDO
  • Stock Information
  • Founded
  • IRWD 1998
  • GDO 2009
  • Country
  • IRWD United States
  • GDO United States
  • Employees
  • IRWD N/A
  • GDO N/A
  • Industry
  • IRWD Biotechnology: Pharmaceutical Preparations
  • GDO Finance Companies
  • Sector
  • IRWD Health Care
  • GDO Finance
  • Exchange
  • IRWD Nasdaq
  • GDO Nasdaq
  • Market Cap
  • IRWD 111.2M
  • GDO 90.2M
  • IPO Year
  • IRWD 2010
  • GDO N/A
  • Fundamental
  • Price
  • IRWD $1.13
  • GDO $11.91
  • Analyst Decision
  • IRWD Buy
  • GDO
  • Analyst Count
  • IRWD 5
  • GDO 0
  • Target Price
  • IRWD $4.94
  • GDO N/A
  • AVG Volume (30 Days)
  • IRWD 1.4M
  • GDO 39.4K
  • Earning Date
  • IRWD 11-06-2025
  • GDO 01-01-0001
  • Dividend Yield
  • IRWD N/A
  • GDO 9.81%
  • EPS Growth
  • IRWD N/A
  • GDO N/A
  • EPS
  • IRWD N/A
  • GDO N/A
  • Revenue
  • IRWD $308,519,000.00
  • GDO N/A
  • Revenue This Year
  • IRWD N/A
  • GDO N/A
  • Revenue Next Year
  • IRWD N/A
  • GDO N/A
  • P/E Ratio
  • IRWD N/A
  • GDO N/A
  • Revenue Growth
  • IRWD N/A
  • GDO N/A
  • 52 Week Low
  • IRWD $0.53
  • GDO $11.21
  • 52 Week High
  • IRWD $5.13
  • GDO $13.04
  • Technical
  • Relative Strength Index (RSI)
  • IRWD 52.75
  • GDO 51.19
  • Support Level
  • IRWD $1.01
  • GDO $11.85
  • Resistance Level
  • IRWD $1.35
  • GDO $11.97
  • Average True Range (ATR)
  • IRWD 0.10
  • GDO 0.08
  • MACD
  • IRWD -0.02
  • GDO -0.02
  • Stochastic Oscillator
  • IRWD 33.33
  • GDO 22.00

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

About GDO Western Asset Global Corporate Defined Opportunity Fund Inc.

Western Asset Global Corp Defined Opp is a closed-end management investment company with a primary investment objective to provide current income. Its secondary objective is to seek capital appreciation. The Fund invests in the United States and foreign corporate fixed-income securities of varying maturities.

Share on Social Networks: